BioSpace News Archive

FDA

AbbVie Submits New Drug Application to U.S. FDA for Investigational ABBV-951 (Foscarbidopa/Foslevodopa) for the Treatment of Advanced Parkinson’s Disease

AbbVie (NYSE: ABBV) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor fluctuations in patients with advanced Parkinson’s disease (PD).

May 20, 2022
·
9 min read
Biotech Beach

ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP Opinion for Gene Therapy

ClearPoint Neuro, Inc. today congratulates partner PTC Therapeutics for receiving a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommending its gene therapy treatment Upstaza™ (eladocagene exuparvovec),

May 20, 2022
·
5 min read
Lone Star Bio

TFF Pharmaceuticals to Participate at the H.C. Wainwright Global Investment Conference

TFF Pharmaceuticals, Inc. announced that President and CEO Glenn Mattes will be virtually participating in the H.C. Wainwright Global Investment Conference being held May 23 - 26, 2022.

May 20, 2022
·
3 min read
Bio NC

G1 Therapeutics Named 2022 Life Sciences Public Company of the Year by Triangle Business Journal

G1 Therapeutics, Inc., a commercial-stage oncology company, announced that it received Triangle Business Journal’s 2022 Company of the Year award, one of two such awards presented at the 2022 Life Sciences Award ceremony.

May 20, 2022
·
2 min read
Virology Specimen Collection Market: Rising Prevalence of Viral Diseases and Emergence of Newer Pathogens are Boosting the Growth of the Market

Growth in the Virology Specimen Collection Market is mainly driven by the rising prevalence of viral diseases, the increasing prevalence of human papillomavirus (HPV) and cervical cancer.

May 20, 2022
·
6 min read
Cancer Biomarkers Role In Immunotherapy Research

Biomarker is a general term which refers to any quantifiable or measurable biological parameter.

May 20, 2022
·
6 min read
B Cell Maturation Antigen Targeted Therapy Clinical Trials Report 2026

B-cell maturation target (BCMA) has recently emerged out as potential target for the development of novel immunotherapies in multiple myeloma.

May 20, 2022
·
4 min read
In Vitro Diagnostics Market Size to Reach US$ 106,914.16 Mn by 2030

The global in vitro diagnostics market was valued at $71,496.16 million in 2020, and is projected to reach US$ 106,914.16 million by 2030, growing at a CAGR of 4.08% from 2021 to 2030.

May 20, 2022
·
9 min read
Biotech Beach

Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 21, 2022

Arcturus Therapeutics Holdings Inc. announced that the Compensation Committee of the Company’s Board of Directors and the Company’s Board of Directors approved inducement grants of stock options to purchase an aggregate of 38,800 shares of Arcturus common stock to five newly-hired employees.

May 20, 2022
·
4 min read
Deals

Zymeworks’ Board of Directors Unanimously Rejects Unsolicited, Non-Binding Proposal

Zymeworks’ Board of Directors Unanimously Rejects Unsolicited, Non-Binding Proposal.

May 20, 2022
·
11 min read